Pharmaceuticals APAC News & Press Release Distribution

Pharmaceuticals

All
Global

IMI launches IMI Corporate Wellness amidst growing concerns for professionals' wellbeing.

HONG KONG, May 28, 2019 /PRNewswire/ -- Integrated Medicine Institute (IMI), Hong Kong's largest natural and integrated medicine clinic, today announced the official launch of its corporate wellness arm. Already at work in global organizations with a presence inHong Kong, IMI Corporate Wellness s...

2019-05-28 09:15 3483

IMI launches IMI Corporate Wellness amidst growing concerns for professionals' wellbeing.

Elekta Unity MR-linac Receives Regulatory Approval From Japanese Ministry of Health, Labour and Welfare

With the potential to transform how clinicians treat cancer, Japan enters a new era of precision radiation medicine with magnetic resonance radiation therapy TOKYO, May 24, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its Elekta Unity magnetic resonance radiation therapy system ha...

2019-05-24 07:05 7424

Cstone partner Agios Announces the Phase 3 ClarIDHy Trial of TIBSOVO (ivosidenib) Achieved its Primary Endpoint

SUZHOU, China, May 23, 2019 /PRNewswire/ -- The partner of CStone Pharmaceuticals ("Cstone"; HKEX:2616), Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) ("Agios") announced that the global Phase 3 ClarIDHy trial of TIBSOVO (ivosidenib) in previously treated cholangiocarcinoma patients with an isocitr...

2019-05-23 18:36 3619

Bened Biomedical Co., Ltd.: Psychobiotic PS128(TM) found to be a potential solution for Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD)

TAIPEI, , May 23, 2019 /PRNewswire/ -- The possible correlation between autism spectrum disorder (ASD) and gut microbiota has long been explored. A recent study, published in《Nutrients》, shows that a specific probiotic supplementation composed ofLactobacillus plantarum PS128 (Psychobiotic PS128™,...

2019-05-23 11:45 2494

Bened Biomedical Co., Ltd.: Psychobiotic PS128(TM) found to be a potential solution for Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD)

Menarini Ricerche at the ASCO Annual Meeting 2019 With Three Different Projects in Oncology

POMEZIA, Italy, May 23, 2019 /PRNewswire/ -- Menarini Ricerche will present three different projects related to the compounds in clinical development SEL24/MEN1703, MEN1611 and MEN1309/OBT076 at the ASCO Annual Meeting 2019 in Chicago. During the poster session "Breast Cancer – Metastatic" on Jun...

2019-05-23 08:00 2588

2019 Competitive Benchmarking of Leading Oncology Organizations: Commercialization Trends That are Shaping the U.S. Solid and Liquid Tumor Marketplaces

PharmaForce International's 2019 Oncology Studies benchmark key expenditures and organizational approaches of leading Oncology sales and marketing organizations around the globe.The United States is just one of five regions that PFI covers in the Oncology market. READING, Pennsylvania, May 23, 2...

2019-05-23 07:00 1555

Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial

Subjects dosed in First-in-Human study of INO-4500 funded by the Coalition for Epidemic Preparedness Innovations Planned for emergency use as a stockpiled vaccine PLYMOUTH MEETING, Pa. and OSLO, Norway, May 21, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO), together with CEPI, ...

2019-05-21 21:00 3885

First Sublingual Ketamine Drug for Treatment of Acute Pain to be Evaluated in End-of-Phase 2 Meeting with FDA

* Racemic sublingual ketamine, Wafermine, is the first sublingual ketamine drug seeking FDA approval for the treatment of moderate to severe acute pain * Wafermine is a Phase 2-ready drug for treatment resistant depression SINGAPORE, May 21, 2019 /PRNewswire/ -- iX Biopharma Ltd (SGX:42C) anno...

2019-05-21 18:11 11142

Merck Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing

- TRANSVAC2, part of the EU's Horizon 2020 program, provides trainings to streamline vaccine manufacturing and development - Merck to offer its M Lab™ Collaboration Center in Molsheim, France for process development skills training DARMSTADT, Germany, May 20, 2019 /PRNewswire/ -- Merck, a leadin...

2019-05-20 20:00 2944

Merck Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing

Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology

SYDNEY, May 20, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into a collaboration with the Alliance for Clinical Trials in Oncology Foundation (Alliance), a US-based cance...

2019-05-20 11:41 4113

Chairman and Managing Director of AMN Life Science Honored at the 10th Asia Pacific Entrepreneurship Awards 2019

NEW DELHI, May 17, 2019 /PRNewswire/ -- With the theme of 'Promoting Inclusive Economic Development Through Sustainable Entrepreneurship',15 top entrepreneurs and enterprises were recognized at the Asia Pacific Entrepreneurship Awards (APEA) 2019 held at Hotel Andaz Delhi Aerocity,India on 18 Apr...

2019-05-17 16:52 2496

Chairman and Managing Director of AMN Life Science Honored at the 10th Asia Pacific Entrepreneurship Awards 2019

Apollo Proton Cancer Centre, Chennai performs India's First Total Marrow Irradiation Procedure

CHENNAI, India, May 15, 2019 /PRNewswire/ -- In a first-ever milestone in cancer treatment inIndia, the Apollo Proton Cancer Center (APCC) in Chennai has successfully performed Total Marrow Irradiation (TMI) as a conditioning protocol prior to Bone Marrow Transplant.

2019-05-15 22:46 2367

Apollo Proton Cancer Centre, Chennai performs India's First Total Marrow Irradiation Procedure

Hangzhou attracts RMB1.5 billion investments in bio-pharmaceutical projects in Q1

HANGZHOU, China, May 15, 2019 /PRNewswire/ -- Hangzhou, capital of east China's Zhejiang Province, has seen seven bio-pharmaceutical projects implemented in the first quarter of the year, with a total investment of1.5 billion yuan, according to the latest data of the Hangzhou Investment Promotion...

2019-05-15 20:56 3141

Ping An Good Doctor and Wyeth Reached Strategic Cooperation

SHANGHAI, May 15, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited("Ping An Good Doctor", or the "Company"; stock code: 01833.HK) announced strategic cooperation with Wyeth Nutrition on15 May 2019. Both sides will utilize their strengths in their respective fields for an all...

2019-05-15 15:20 5866

FDA Approves BAVENCIO® (avelumab) plus Axitinib Combination for Patients with Advanced Renal Cell Carcinoma

DARMSTADT, Germany and NEW YORK, May 15, 2019 /PRNewswire/ -- Not intended for US, Canada and UK-based media * BAVENCIO is the first anti-PD-L1 in combination with axitinib approved by FDA for first-line treatment of patients with advanced renal cell carcinoma (RCC) * Phase III study show...

2019-05-15 08:25 3581

Pneuma Respiratory and Leads Biolabs, Inc. Announce Partnership

BOONE, North Carolina, May 15, 2019 /PRNewswire/ -- Pneuma Respiratory, Inc., developer of a proprietary breath-activated digital inhaler (BDI), and Leads Biolabs Inc. announce an agreement granting Pneuma an exclusive license to develop Leads Biolabs' panel of immuno-oncology monoclonal antibodi...

2019-05-15 07:53 2261

Sekisui Diagnostics Invests $1.9 million in Microbial Biopharma CDMO Business

LEXINGTON, Massachusetts, May 15, 2019 /PRNewswire/ -- Sekisui Diagnostics Enzyme business announces the completion of a newBioProcess Innovation Centre at the site in Maidstone, Kent by the end of 2019, following a$1.9 million investment. This investment is part of a long-term investment strateg...

2019-05-15 03:11 2212

Sekisui Diagnostics Invests $1.9 million in Microbial Biopharma CDMO Business

Peritech Pharma Granted Patents for China and Russia

HERZLIYA, Israel, May 14, 2019 /PRNewswire/ -- Peritech Pharma , a specialty anal-rectal pharmaceutical company, today announced it has been granted patents coveringChina and Russia for its drug delivery platform used for two of its over-the-counter products, PP-110 f...

2019-05-14 08:55 3172

Frost & Sullivan Publishes Annual Update on BioLineRx

TEL AVIV, Israel, May 13, 2019 /PRNewswire/ -- The TASE analysis project was launched in 2016 in order to raise investor awareness to TASE listed technology and life-science companies and the markets in which these companies operate, thus creating appropriate pricing and increasing the exposure o...

2019-05-13 23:46 1181

NeuroVive's IND for Clinical Development of NeuroSTAT Approved by FDA

LUND, Sweden, May 10, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the US Food and Drug Administration, FDA, has approved NeuroVive's IND (Investigational New Drug) application, enabling clinical studies in the US with the company's ...

2019-05-10 15:05 5668

1 ... 177 178 179180181